Associated Papers
Catching the Silent Culprits: TERT Promoter Mutation Screening of Minimally Invasive Follicular and Oncocytic Thyroid Carcinoma in Clinical Practice.
Hellgren LS et al.
Endocrine Pathology, 2024
Prognostic Impact of TERT Promoter Mutations in Adult-Type Diffuse Gliomas Based on WHO2021 Criteria.
Lee Y et al.
Cancers, 2024
Genomic profiles of IDH-mutant gliomas: MYCN-amplified IDH-mutant astrocytoma had the worst prognosis.
Lee K et al.
Scientific Reports, 2023
Human TERT Promoter Mutations in Atypical and Anaplastic Meningiomas.
Mellai M et al.
Diagnostics (basel, Switzerland), 2021
34573966 (PubMed )
Supplement: diagnostics-11-01624-s001.zip › diagnostics-1327423-supplementary.pdf
Establishment and Validation of the Detection of TERT Promoter Mutations by Human Gliomas U251 Cell Lines.
Bai H et al.
Biomed Research International, 2021
34159191 (PubMed )
Supplement: 3271395.f1.docx
Clinical Routine TERT Promoter Mutational Screening of Follicular Thyroid Tumors of Uncertain Malignant Potential (FT-UMPs): A Useful Predictor of Metastatic Disease.
Hysek M et al.
Cancers, 2019
Prognostic significance of human telomerase reverse transcriptase promoter region mutations C228T and C250T for overall survival in spinal chordomas.
Bettegowda C et al.
Neuro-oncology, 2019
Select a paper to view details